CRNXCRINETICS PHARMACEUTICALS IN
CUSIP 22663K107 · common stock
No tracked investor reported shares of CRINETICS PHARMACEUTICALS IN (CRNX) for Q3 2026. 3 investors sold out this quarter, including Julian Baker.
Holders · Q3 2026
0
New holders
0
Value held
$0
Quarter-end price (est.)
—
Investors holding CRNX · Q3 2026
No tracked investor reported shares this quarter.
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Julian Baker | 0.44% | 2,351,465 | $88M | EXIT |
| Adar1 Capital Management | 2.09% | 1,222,080 | $45.7M | EXIT |
| Ken Fisher | 0.01% | 741,553 | $27.7M | EXIT |